Penile Botox Cost in 2026: What Patients Are Actually Paying For

Introduction: Why “Penile Botox Cost” Is the Wrong Question for Most Men Who Search It

Men who type “penile Botox cost” into a search bar are rarely asking one question. They are usually asking one of three unrelated questions packed into the same phrase. Some want a cosmetic treatment that smooths the appearance of the penis in its flaccid state. Some want an off-label urological treatment for premature ejaculation (PE), erectile dysfunction (ED), or Peyronie’s disease. A large share want something Botox cannot provide: more size or girth.

That last point deserves a plain statement at the outset. Botox does not make the penis bigger. It relaxes muscle. It does not add volume, tissue, or girth.

This guide offers a transparent cost breakdown organized by injection site and clinical goal. It draws on peer-reviewed sources, including a 2026 systematic review in Andrology (Wiley), a meta-analysis of randomized controlled trials indexed on PubMed, research presented through the American Urological Association, and a PLOS ONE meta-analysis, rather than med-spa marketing copy. Men evaluating these options deserve clinical clarity, not vague “enhancement” language.

One disclosure that many competing pages bury or omit belongs at the top: botulinum toxin is not FDA-approved for any genital or urological use. Every penile application is off-label.

The Three Things Hiding Behind “Penile Botox” Searches

A single search term captures three clinically distinct procedures. Each has a different goal, a different injection site, and a very different evidence base. Until a man knows which category he actually belongs in, any price he sees is essentially meaningless.

1. Cosmetic Flaccid-Appearance Smoothing (“P-Tox,” “Bocox,” “ShowTox”)

Med-spas typically market this as a treatment for the flaccid state, often aimed at reducing retraction or “turtling.” The injections usually target the prepuce, subcoronal region, or superficial subcutaneous tissue rather than deeper structures. Branded names such as P-Tox, Bocox, ShowTox, and Firm-X are largely marketing packaging around the same class of injectable.

2. Off-Label Urological Treatment (PE, ED, Peyronie’s Disease)

This category is research-driven. Investigators have studied injection into the bulbospongiosus muscle for premature ejaculation, intracavernosal injection for erectile dysfunction, and intralesional injection into scar plaque for Peyronie’s disease. These procedures are generally performed by urologists evaluating functional outcomes, not by cosmetic providers.

3. Size/Girth Enhancement (The Goal Botox Cannot Deliver)

No peer-reviewed evidence shows Botox producing a meaningful permanent or even temporary increase in girth or length. The mechanism simply does not match the goal: size change requires added tissue volume, and Botox only relaxes muscle. Men in this category need a different procedure entirely, which is addressed later in this guide.

How Botox Actually Works, and Why the Injection Site Changes Everything

Botulinum toxin blocks the release of acetylcholine at the neuromuscular junction, producing temporary, localized muscle relaxation. That mechanism is identical everywhere in the body. What changes is the anatomical target, and therefore the clinical effect:

• Prepuce/subcoronal injection: cosmetic, superficial, aimed at appearance
• Bulbospongiosus injection: targets the pelvic floor muscle involved in ejaculation (PE)
• Intracavernosal injection: targets smooth muscle within the erectile chambers (ED)
• Intralesional injection: delivered into a Peyronie’s plaque

This distinction has real consequences. A 2026 case series evaluating subcoronal and prepuce injection, the region closest to what most cosmetic “penile Botox” targets, found it did not meaningfully alter ejaculatory latency. That contrasts with the bulbospongiosus-targeted injections used in clinical PE research, consistent with trial protocols registered on ClinicalTrials.gov.

Key takeaway: the injection site a man is sold matters more than the brand name or the unit count on the invoice.

Penile Botox Cost Breakdown by Goal: What 2026 Pricing Actually Looks Like

The figures below reflect Botox-specific treatments, both cosmetic and off-label urological. They do not apply to girth enhancement, which is a separate procedure covered later.

Cosmetic Flaccid-Appearance Packages: $300–$1,890

• Seattle med-spas advertise packages as low as $299–$400 for 30 units
• Boston providers quote fixed fees around $1,200
• Some clinics charge $1,600 for 100 units
• Branded packages such as Firm-X reach $1,890

Bundling pushes prices higher. Scrotal Botox (“Scrotox”) alone runs $500–$3,600, and New York City packages combining penile Botox with a P-Shot or exosomes commonly land between $1,500 and $3,600. This tier is purely aesthetic, with no functional or medical claim behind it.

Off-Label Urological Treatment: $1,000–$4,500+ Per Session

Comprehensive Urology estimates $1,000–$3,000 per session for base-of-penis injections, within a broader penile enlargement cost spectrum of $1,000–$25,000. Medical tourism aggregator Bookimed reports a global average near $645 (range $359–$750) while noting US clinic quotes up to $2,500. A separate Bookimed table places US pricing at $2,500–$4,500 per session.

The single-session figure understates the true cost. Effects last only 3 to 6 months, so real annual spending typically runs 2 to 4 times the per-session price. On safety, transient penile pain appears in roughly 1.5–6% of cases across urologic studies, mostly mild, with no major systemic safety signal in small trials to date.

Medical Tourism Pricing: Why the Discount Comes With a Different Risk Profile

Overseas pricing can be up to 88% cheaper. That gap is not a recommendation; it reflects differences in regulatory oversight, injector credentialing, product sourcing, and access to follow-up care. For an injection into one of the most sensitive areas of the body, the qualifications of the person holding the syringe deserve more weight than the size of the discount.

Why Prices Vary So Wildly: The Four Real Cost Drivers

1. Unit count: cosmetic treatments may use 30 to 100 units; urological protocols vary by study design.
2. Toxin brand: Botox and other botulinum toxin formulations carry different acquisition costs.
3. Injection site and technique: deeper, more technically demanding work (intracavernosal, intralesional) commands higher fees than superficial subcoronal injection.
4. Bundling: adding a P-Shot, exosomes, or Scrotox inflates package pricing, which matters when comparing quotes line by line.

What the Peer-Reviewed Research Actually Shows

The evidence below comes from published research rather than testimonials: the 2026 Andrology systematic review, a PubMed-indexed meta-analysis of RCTs, an AUA journal study, and a PLOS ONE meta-analysis.

Premature Ejaculation: The Strongest Evidence Base

A meta-analysis of 8 RCTs (n=742) found Botox significantly increased intravaginal ejaculatory latency time (IELT) by a mean of 17.63 seconds. The PLOS ONE review found BoNT-A carries a higher overall adverse event rate but does not increase the risk of dribbling or erectile dysfunction. This evidence applies specifically to bulbospongiosus-targeted injection, not cosmetic prepuce injection.

Erectile Dysfunction: Promising but Early

The same meta-analysis reported SHIM score improvements of 3.25 points at 2 weeks and 5.30 points at 3 months. A systematic review of intracavernosal injection identified mild, transient penile pain (1.5–6%) as the most common adverse event. The 2026 Andrology review summarized the field as promising but preliminary, limited by small, heterogeneous studies and the absence of large randomized controlled trials.

Peyronie’s Disease: Why Botox Is Not the Recommended First-Line Option

Botox is neither FDA-approved nor recommended by the AUA, EAU, or ISSM for Peyronie’s disease. Guideline bodies endorse collagenase clostridium histolyticum (Xiaflex) instead. Evidence for Botox conflicts: one small study showed a modest curvature reduction of about 7.9°, while an AUA-presented RCT found no significant improvement in curvature or IIEF scores. Cleveland Clinic and a Cochrane-affiliated review both confirm collagenase as the evidence-backed option, approved for curvatures between 30 and 90 degrees.

The Off-Label Reality and Safety Disclosures Every Man Should See Before Booking

• Off-label status: botulinum toxin is not FDA-approved for any genital or urological indication. Penile, scrotal, and “sexual wellness” uses are all off-label, and providers are obligated to disclose this.
• Boxed warning: every Botox product carries an FDA boxed warning for “Distant Spread of Toxin Effect,” which can cause muscle weakness, drooping eyelids, and trouble swallowing or breathing, and has been linked to rare deaths. Symptoms can appear hours to weeks after injection.
• Counterfeit products: in late 2025, the FDA sent warning letters to 18 websites selling counterfeit or unapproved botulinum toxin, following injury reports that included botulism-like effects.

Ultra-low-cost offers, such as sub-$400 packages, should be treated as a red flag that warrants scrutiny of product sourcing and injector licensing.

Why Botox Can’t Deliver What Many Men Searching This Term Actually Want

For the man whose real concern is size or confidence, the answer is direct: muscle relaxation is not tissue growth, and no study shows Botox producing measurable gains in girth or length. Every Botox effect is temporary, fading within 3 to 6 months, while the results men typically associate with “enhancement” last 18 to 24 months or longer.

None of this diminishes Botox’s legitimate off-label role in PE and ED research or its place as a cosmetic smoothing option. The point is fit. If the goal is fullness, girth, or sexual confidence rather than symptom management, the clinically appropriate category is volumizing dermal filler.

If the Real Goal Is Size, Fullness, or Confidence: How Girth Enhancement Actually Works

Hyaluronic acid (HA) filler-based girth enhancement is purpose-built for volume. Unlike a neurotoxin, filler physically adds material beneath the skin. At Stoller Medical Group, the procedure uses Belefil®, a medical-grade, biocompatible HA-based filler designed for soft tissue augmentation, placed beneath the penile skin to enhance girth and volume. The treatment is outpatient and non-surgical, takes under one hour, and requires no cutting and no general anesthesia.

The Real Cost Structure: Why Girth Enhancement Is Priced by Syringe

Girth enhancement is priced per syringe, not as a flat package. Pricing starts at $7,500 and increases depending on the patient’s desired results. Most men begin with a minimum of 10 syringes, and the average first procedure uses 15 syringes.

The upfront investment is higher than a single Botox session, but the comparison shifts when measured by duration. Botox requires repeat treatment every 3 to 6 months indefinitely. Filler results last 18 to 24 months, with 80–90% permanent improvement in girth and volume, which makes the cost per month of results considerably more favorable.

The practice follows a staged treatment philosophy: conservative, incremental sessions rather than one dramatic procedure, which supports better symmetry, lower risk, and smoother outcomes. Follow-up is typically scheduled 2 to 3 months after the initial treatment, with optional touch-ups for maintenance.

What Results and Recovery Actually Look Like

• Outcome: up to 1 to 1.5 inches of added girth, visible immediately after the procedure
• Recovery: back on one’s feet in about 10 days, compared with 40+ days for other permanent fillers
• Intimacy: sexual activity can typically resume within 7 to 10 days
• Feel and function: results look and feel natural in both flaccid and erect states, with normal sensation and function maintained

Glans enlargement and scrotal enhancement can be discussed during the same consultation, and glans treatment can be performed alongside shaft treatment.

Choosing the Right Treatment and Provider: A Decision Framework

Step one is matching the goal to the category:

• PE or ED symptom relief: off-label urological Botox under a qualified urologist may be reasonable, with modest, evidence-based expectations.
• Peyronie’s curvature: a conversation with a physician about collagenase (Xiaflex) is the guideline-supported path.
• Size, fullness, or confidence: HA filler-based girth enhancement is the appropriate category, not Botox.

Step two is vetting the provider:

• Confirm off-label disclosure is provided in writing
• Ask exactly which toxin or filler product is used, where it is sourced, and its FDA status
• Verify physician credentials and procedure volume
• Treat prices far below market range as a safety red flag, not a bargain

Conclusion: Paying for the Right Procedure, Not Just a Lower Price

“Penile Botox” is really three different conversations: cosmetic smoothing, off-label urological treatment, and size enhancement. Each carries its own evidence, risk, and cost profile. Transparent, goal-specific pricing is what separates credible providers from overhyped or counterfeit-risk clinics.

Botox can be a legitimate, evidence-supported off-label tool for PE and ED, and a reasonable cosmetic option for flaccid smoothing. It is not a size-enhancement solution, and men whose real goal is girth or confidence deserve to hear that before spending money. Stoller Medical Group’s staged, physician-led, safety-first approach reflects the standard every patient should expect, regardless of which path he chooses.

Ready for a Clear, Honest Assessment of the Options?

Many men have spent years assuming no real solution existed. A free, confidential consultation with Stoller Medical Group offers the chance to clarify actual goals, whether symptom relief or aesthetic and confidence outcomes, before committing to anything.

Evaluations are led by Dr. Roy B. Stoller, a board-certified physician with 25+ years in aesthetic and restorative medicine and a practice record of 15,000+ enlargement procedures. Discretion and privacy are standard at all five locations: Manhattan, Long Island, Albany, Pennsylvania, and Minnesota.

Rather than relying on generic “penile Botox cost” estimates, prospective patients can book a free consultation to receive a personalized, transparent treatment plan and cost breakdown built around their anatomy and goals.